A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC
ConclusionTaken together, a feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC and targeting the feedback loop could be a promising approach to overcome drug resistance.
Source: Cancer and Metabolism - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | G6PD | Hepatocellular Carcinoma | Liver | Liver Cancer | Oral Cancer | Study | Urology & Nephrology